The United States market has experienced a positive trend, rising 3.5% over the last week and 20% over the past year, with earnings projected to grow by 17% annually in the coming years. In this environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst overall market growth.
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Zeta Global Holdings (ZETA) | $25.56 | $53.12 | 51.9% |
| Western Digital (WDC) | $451.52 | $1407.61 | 67.9% |
| Warrior Met Coal (HCC) | $89.62 | $165.01 | 45.7% |
| Swarmer (SWMR) | $34.60 | $66.88 | 48.3% |
| Robert Half (RHI) | $40.68 | $79.11 | 48.6% |
| Rayonier (RYN) | $21.43 | $43.36 | 50.6% |
| Natera (NTRA) | $265.38 | $538.52 | 50.7% |
| Mobileye Global (MBLY) | $8.42 | $16.24 | 48.1% |
| HawkEye 360 (HAWK) | $24.71 | $48.01 | 48.5% |
| Advanced Energy Industries (AEIS) | $323.91 | $654.47 | 50.5% |
Let's take a closer look at a couple of our picks from the screened companies.
Overview: Sotera Health Company offers sterilization solutions, lab testing, and advisory services to the healthcare industry across the United States, Canada, Europe, and internationally, with a market cap of approximately $5.13 billion.
Operations: Sotera Health's revenue is derived from providing sterilization solutions, lab testing, and advisory services to the healthcare sector across various regions including the United States, Canada, and Europe.
Estimated Discount To Fair Value: 29.4%
Sotera Health is trading at US$18.91, significantly below its estimated future cash flow value of US$26.79, suggesting undervaluation based on discounted cash flows. Despite being dropped from several growth benchmarks, recent earnings showed strong improvement with net income rising to US$53.64 million for Q2 2026 from US$7.96 million a year ago. However, interest payments are not well covered by earnings, which could pose financial challenges moving forward.
Overview: Owens Corning is a company that supplies residential and commercial building products across the United States, Europe, the Asia Pacific, and internationally, with a market cap of approximately $12.05 billion.
Operations: Owens Corning's revenue is derived from its residential and commercial building products offered across various regions, including the United States, Europe, and the Asia Pacific.
Estimated Discount To Fair Value: 10.5%
Owens Corning is trading at US$150.6, slightly below its estimated future cash flow value of US$168.27, indicating potential undervaluation. The company reported Q2 2026 sales of US$2.76 billion, with net income declining to US$226 million from the previous year’s US$363 million. Despite a high debt level and slower revenue growth than the market, Owens Corning's forecasted earnings growth and strategic share buybacks enhance its appeal based on discounted cash flows.
Overview: Robert Half Inc. offers talent solutions and business consulting services both in the United States and internationally, with a market cap of approximately $4.08 billion.
Operations: The company generates revenue through its segments: Protiviti ($1.91 billion), Contract Talent Solutions ($3.43 billion), and Permanent Placement Talent Solutions ($439.69 million).
Estimated Discount To Fair Value: 48.6%
Robert Half is trading at US$40.68, significantly below its estimated future cash flow value of US$79.11, highlighting potential undervaluation. Despite a decline in Q2 2026 net income to US$26.32 million from the previous year's US$40.97 million, earnings are forecasted to grow substantially over the next three years, outpacing the broader market's growth rate. However, current profit margins and dividend coverage remain areas of concern amidst slower revenue growth projections compared to market averages.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com